Sickle Cell Diseases

Department of Health and Social Care written question – answered on 23rd May 2019.

Alert me about debates like this

Photo of Diana R. Johnson Diana R. Johnson Labour, Kingston upon Hull North

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2018 to Question 135010 on Sickle Cell Diseases, if he will provide updated estimates of the costs to the NHS of treating sickle cell anaemia in (a) England (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.

Photo of Diana R. Johnson Diana R. Johnson Labour, Kingston upon Hull North

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 December 2014 to Question 216527 on Sickle Cell Diseases, if he will provide updated estimates of the costs to NHS of admitted patient care episodes for sickle cell anaemia in (a) England, (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.

Photo of Seema Kennedy Seema Kennedy The Parliamentary Under-Secretary for Health and Social Care

NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.

Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease

Region

Hub

2015/16

2016/17

2017/18

£ million

£ million

£ million

London

29.9

31.0

44.8

Midlands and East

East of England

1.6

1.7

3.3

East Midlands

0.8

0.8

1.4

West Midlands

2.7

2.5

3.2

Midlands and East Total

5.1

5.0

7.9

North

North East

0.1

0.2

0.2

North West

2.8

2.3

2.3

Yorkshire & Humber

1.1

0.5

0.9

North Total

4.0

3.0

3.4

South

South East

1.8

1.9

2.6

South West

0.2

0.2

0.7

Wessex

0.5

0.5

0.9

South Total

2.5

2.5

4.2

41.6

41.5

60.4

Source: Costs extracted from the annual CCG exercise.

Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.